Centogene, Parkinson's Institute Ally on Genetic Screening | GenomeWeb

NEW YORK (GenomeWeb) – The Parkinson's Institute and Clinical Center announced on Friday a collaboration with Germany's Centogene on panel-based genetic screening for a US patient cohort.

Under the partnership, patients will be screened using a large, customized panel to characterize genetic variants associated with development and treatment of Parkinson's disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.